Virtu Financial LLC Celldex Therapeutics, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$35.22 - $51.88 $691,861 - $1.02 Million	19,644 New	19,644 $824,000
Q4 2019 Feb 04, 2020	SELL	$2.11 - $2.8 $29,525 - $39,180	-13,993 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$2.05 - $2.75 $28,685 - $38,480	13,993 New	13,993 $30,000
Q2 2019 Aug 13, 2019	SELL	$2.43 - $5.09 $62,757 - $131,454	-25,826 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$3.45 - $10.35 $89,099 - $267,299	25,826 New	25,826 $127,000

199

65.9M

1.68M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.15B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.